$APVO - 100% Clinical Benefit Rate Achieved in Phase 1b Trial Evaluating APVO436 in Combination with Venetoclax and Azacitidine for Venetoclax Treatment Naïve Patients with Acute Myeloid Leukemia (AML): https://finance.yahoo.com/news/100-clinical-benefit-rate-achieved-123500248.html
$HTGM - HTG Molecular Diagnostics Announces the Next Event in its RNA Profiling in Drug Discovery KOL Webcast Series (12/9/2022): https://finance.yahoo.com/news/htg-molecular-diagnostics-announces-next-130100207.html
$KWE - KWESST Provides Corporate Update Following NASDAQ Listing and Completion of Financing: https://finance.yahoo.com/news/kwesst-provides-corporate-following-nasdaq-130900085.html
$REBN - Reborn Coffee Expands to South Korea with Acquisition of Specialty Coffee Shop and Roasting R&D Facility in Daejeon (12/8/2022): https://finance.yahoo.com/news/reborn-coffee-expands-south-korea-133100962.html